• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IL-31 产生和 IL-31 介导的瘙痒传递的分子基础:从生物学到药物开发。

The molecular basis for IL-31 production and IL-31-mediated itch transmission: from biology to drug development.

机构信息

Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

出版信息

Int Immunol. 2021 Nov 25;33(12):731-736. doi: 10.1093/intimm/dxab065.

DOI:10.1093/intimm/dxab065
PMID:34491348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8633599/
Abstract

Atopic dermatitis (AD) is one of the most prevalent chronic inflammatory skin diseases in the world. It is characterized by recurrent eczematous lesions and intense itch, and many cytokines are involved in the pathogenesis of AD. Among them, much attention has been paid to interleukin 31 (IL-31) as an AD-associated itch mediator. IL-31 is mainly produced by CD4+ helper T cells and transmits the signals via a heterodimeric receptor composed of IL-31 receptor A (IL-31RA) and oncostatin M receptor (OSMR), both of which are expressed in dorsal root ganglion (DRG) neurons. However, the molecular mechanisms of how IL-31 is produced in helper T cells upon stimulation and transmits the itch sensation to the brain were largely unknown. Recently, by using original mouse models of AD, we have identified endothelial PAS domain 1 (EPAS1) and neurokinin B (NKB) as key molecules critical for IL-31 production and IL-31-mediated itch transmission, respectively. These molecules could be novel drug targets for AD-associated itch. This review highlights our recent findings, which show the functional significance of these molecules in the IL-31-induced itch sensation, referring to their application to drug development.

摘要

特应性皮炎(AD)是世界上最常见的慢性炎症性皮肤病之一。其特征为反复发作的湿疹样皮损和剧烈瘙痒,许多细胞因子参与 AD 的发病机制。其中,白细胞介素 31(IL-31)作为一种与 AD 相关的瘙痒介质受到了广泛关注。IL-31 主要由 CD4+辅助 T 细胞产生,并通过由白细胞介素 31 受体 A(IL-31RA)和肿瘤坏死因子受体超家族成员 11(OSMR)组成的异二聚体受体传递信号,这两种受体均在背根神经节(DRG)神经元中表达。然而,IL-31 在辅助 T 细胞受到刺激时产生以及将瘙痒感传递到大脑的分子机制在很大程度上是未知的。最近,通过使用 AD 的原始小鼠模型,我们确定了内皮 PAS 结构域蛋白 1(EPAS1)和神经激肽 B(NKB)分别是 IL-31 产生和 IL-31 介导的瘙痒传递的关键分子。这些分子可能是 AD 相关瘙痒的新型药物靶点。本综述强调了我们最近的发现,这些发现显示了这些分子在 IL-31 诱导的瘙痒感中的功能意义,并提到了它们在药物开发中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c9/8633599/c37af4a38bf7/dxab065_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c9/8633599/dadf2667c78a/dxab065_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c9/8633599/c37af4a38bf7/dxab065_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c9/8633599/dadf2667c78a/dxab065_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3c9/8633599/c37af4a38bf7/dxab065_fig2.jpg

相似文献

1
The molecular basis for IL-31 production and IL-31-mediated itch transmission: from biology to drug development.IL-31 产生和 IL-31 介导的瘙痒传递的分子基础:从生物学到药物开发。
Int Immunol. 2021 Nov 25;33(12):731-736. doi: 10.1093/intimm/dxab065.
2
New mechanism underlying IL-31-induced atopic dermatitis.IL-31 诱导特应性皮炎的新机制。
J Allergy Clin Immunol. 2018 May;141(5):1677-1689.e8. doi: 10.1016/j.jaci.2017.12.1002. Epub 2018 Feb 7.
3
Oncostatin M suppresses expression in dorsal root ganglia and interleukin-31-induced itching.抑瘤素 M 抑制背根神经节中的表达和白细胞介素-31 诱导的瘙痒。
Front Immunol. 2023 Nov 16;14:1251031. doi: 10.3389/fimmu.2023.1251031. eCollection 2023.
4
IL-20 promotes cutaneous inflammation and peripheral itch sensation in atopic dermatitis.IL-20 促进特应性皮炎的皮肤炎症和外周瘙痒感。
FASEB J. 2022 Jun;36(6):e22334. doi: 10.1096/fj.202101800R.
5
Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis.白细胞介素-31及其受体表达细胞在特应性皮炎皮肤中的分布。
J Dermatol Sci. 2014 Jun;74(3):229-35. doi: 10.1016/j.jdermsci.2014.02.009. Epub 2014 Mar 12.
6
Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound.一种小分子化合物对EPAS1驱动的IL-31产生的靶向抑制作用。
J Allergy Clin Immunol. 2021 Aug;148(2):633-638. doi: 10.1016/j.jaci.2021.03.029. Epub 2021 Apr 2.
7
Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis.白细胞介素-31 和白细胞介素-31 受体:特应性皮炎的新治疗靶点。
Exp Dermatol. 2018 Apr;27(4):327-331. doi: 10.1111/exd.13533.
8
IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis.炎症细胞中的白细胞介素 31 表达在特应性皮炎中优先升高。
Acta Derm Venereol. 2012 Jan;92(1):24-8. doi: 10.2340/00015555-1191.
9
Interleukin-31 and Pruritic Skin.白细胞介素-31与瘙痒性皮肤
J Clin Med. 2021 Apr 28;10(9):1906. doi: 10.3390/jcm10091906.
10
Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.结节性痒疹的瘙痒强度与皮肤白介素-31、成纤维细胞生长因子 22、白细胞介素-31 受体α和白细胞介素-31 受体β密切相关。
Exp Dermatol. 2021 Jun;30(6):804-810. doi: 10.1111/exd.14279. Epub 2021 Feb 1.

引用本文的文献

1
iMSC-Derived Extracellular Vesicles Improve Atopic Dermatitis by Augmenting Skin Barrier Integrity and Inhibiting Inflammation, Pruritus and Th2 Immune Responses.间充质干细胞衍生的细胞外囊泡通过增强皮肤屏障完整性、抑制炎症、瘙痒和Th2免疫反应来改善特应性皮炎。
J Extracell Biol. 2025 Jun 23;4(6):e70067. doi: 10.1002/jex2.70067. eCollection 2025 Jun.
2
An OX-Tra'Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis.一个非比寻常的故事:OX40 和 OX40L 在特应性皮炎中的作用。
Cells. 2024 Mar 28;13(7):587. doi: 10.3390/cells13070587.
3
Characterization of the Pro-Inflammatory and Pruritogenic Transcriptome in Skin Lesions of the Experimental Canine Atopic Acute IgE-Mediated Late Phase Reactions Model and Correlation to Acute Skin Lesions of Human Atopic Dermatitis.

本文引用的文献

1
Interleukin-31 and Pruritic Skin.白细胞介素-31与瘙痒性皮肤
J Clin Med. 2021 Apr 28;10(9):1906. doi: 10.3390/jcm10091906.
2
A Second Wave for the Neurokinin Tac2 Pathway in Brain Research.神经激肽 Tac2 通路在大脑研究中的第二次浪潮。
Biol Psychiatry. 2021 Aug 1;90(3):156-164. doi: 10.1016/j.biopsych.2021.02.016. Epub 2021 Feb 23.
3
Targeted inhibition of EPAS1-driven IL-31 production by a small-molecule compound.一种小分子化合物对EPAS1驱动的IL-31产生的靶向抑制作用。
实验性犬特应性急性IgE介导的迟发性反应模型皮肤损伤中促炎和致痒转录组的特征及其与人类特应性皮炎急性皮肤损伤的相关性
Vet Sci. 2024 Mar 1;11(3):109. doi: 10.3390/vetsci11030109.
4
Dendritic cells under allergic condition enhance the activation of pruritogen-responsive neurons via inducing itch receptors in a co-culture study.变应条件下的树突状细胞通过在共培养研究中诱导瘙痒受体增强了致痒原反应神经元的激活。
BMC Immunol. 2024 Feb 12;25(1):17. doi: 10.1186/s12865-024-00604-4.
5
Role of cytokine in malignant T-cell metabolism and subsequent alternation in T-cell tumor microenvironment.细胞因子在恶性T细胞代谢及随后T细胞肿瘤微环境改变中的作用。
Front Oncol. 2023 Sep 7;13:1235711. doi: 10.3389/fonc.2023.1235711. eCollection 2023.
6
Role of burn severity and posttraumatic stress symptoms in the co-occurrence of itch and neuropathic pain after burns: A longitudinal study.烧伤严重程度和创伤后应激症状在烧伤后瘙痒与神经性疼痛共发中的作用:一项纵向研究。
Front Med (Lausanne). 2022 Oct 12;9:997183. doi: 10.3389/fmed.2022.997183. eCollection 2022.
J Allergy Clin Immunol. 2021 Aug;148(2):633-638. doi: 10.1016/j.jaci.2021.03.029. Epub 2021 Apr 2.
4
Interleukin-31 as a Clinical Target for Pruritus Treatment.白细胞介素-31作为瘙痒治疗的临床靶点
Front Med (Lausanne). 2021 Feb 12;8:638325. doi: 10.3389/fmed.2021.638325. eCollection 2021.
5
Elevated interleukin 31 serum levels in hemodialysis patients are associated with uremic pruritus.血液透析患者血清白细胞介素 31 水平升高与尿毒症瘙痒有关。
Cytokine. 2021 Feb;138:155369. doi: 10.1016/j.cyto.2020.155369. Epub 2020 Nov 19.
6
Tacr3/NK3R: Beyond Their Roles in Reproduction.Tacr3/NK3R:超越生殖领域的作用。
ACS Chem Neurosci. 2020 Oct 7;11(19):2935-2943. doi: 10.1021/acschemneuro.0c00421. Epub 2020 Sep 25.
7
The Cytokine TGF-β Induces Interleukin-31 Expression from Dermal Dendritic Cells to Activate Sensory Neurons and Stimulate Wound Itching.细胞因子 TGF-β 从皮肤树突状细胞诱导白细胞介素-31 的表达,从而激活感觉神经元并刺激伤口瘙痒。
Immunity. 2020 Aug 18;53(2):371-383.e5. doi: 10.1016/j.immuni.2020.06.023. Epub 2020 Jul 15.
8
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.针对伴有瘙痒的特应性皮炎的 Nemolizumab 与局部治疗药物的试验。
N Engl J Med. 2020 Jul 9;383(2):141-150. doi: 10.1056/NEJMoa1917006.
9
Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis.尼莫利珠单抗治疗中重度结节性痒疹的试验。
N Engl J Med. 2020 Feb 20;382(8):706-716. doi: 10.1056/NEJMoa1908316.
10
DOCK family proteins: key players in immune surveillance mechanisms.DOCK 家族蛋白:免疫监视机制中的关键分子。
Int Immunol. 2020 Jan 9;32(1):5-15. doi: 10.1093/intimm/dxz067.